Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates SAN DIEGO, June 28, 2022 - Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match … [Read more...] about Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
genomics
Achilles Therapeutics raises £100 million in oversubscribed Series B financing
Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing personalised cancer immunotherapies, today announces it has closed a £100 million Series B financing led by incoming U.S. investor RA Capital Management, corner-stoned by founding investor Syncona and joined by important new investors including Forbion, Invus, Perceptive Advisors and Redmile … [Read more...] about Achilles Therapeutics raises £100 million in oversubscribed Series B financing